DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zxvvs2/healthcare) has announced the addition of GlobalData's new report "Healthcare, Regulatory and Reimbursement Landscape - Jordan" to their offering.
The report is an essential source of information and provides an analysis of the healthcare, regulatory and reimbursement landscape of Jordan. The report identifies the key trends in the healthcare market of Jordan. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Jordan. Most importantly, the report provides valuable insights on the trends and segmentation of the pharmaceutical market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Our team of industry experts.
Jordan has a small population, approximately 6.2 million in 2011. However, the population of Jordan is increasing due to a high birth rate and low mortality rate, along with an increase in life expectancy. The increase in the population of the working-age sector of the population will support the country's development, but the country's high unemployment rate is a cause of concern for policy planners. The pharmaceutical market in Jordan was estimated at $487.6m in 2011 and is expected to reach approximately $1,112.1m by 2020, at a projected Compound Annual Growth Rate (CAGR) of 9.6% between 2012 and 2020.
The positive trend in the healthcare market of Jordan can be attributed primarily to:
- Increase in exports of pharmaceutical products
- High share of public health insurance
- Increasing access to healthcare facilities
- Government initiatives in healthcare sector
- Increasing affordability
- An overview of the pharmaceutical market of Jordan including the market size, market segmentation, key drivers and barriers for the market.
- Profiles and SWOT analyses of the major players in the pharmaceutical market. Key players covered for the pharmaceutical market are Hikma Pharmaceuticals, Dar al Dawa Development & Investment, Jordan Pharmaceutical Manufacturing and Pharma International.
- An insightful review of the reimbursement and regulatory landscape. The analysis includes details of the healthcare reimbursement process, regulatory agencies and marketing authorization process for new drugs in Jordan.
- A detailed analysis of the political and economic environment of Jordan, including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of Jordan.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the healthcare market of Jordan.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Jordanian healthcare market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Jordan.
For more information visit http://www.researchandmarkets.com/research/zxvvs2/healthcare